Postbiotics
MB1
MB1 is a heat-treated probiotic derived from the patented gluten-degrading strain MB0601. Developed as a functional postbiotic powder, it is designed for use in foods, additives, and products that require heat stability during manufacturing.
The parent strain MB0601 was patented in 2021 through collaborative research with government-funded institutes. It is known for breaking down gluten while also supporting digestion. Research has shown that MB0601 improves digestive health by stimulating the hormone gastrin and enhancing pancreatic amylase activity, which helps break down carbohydrates.
This technology has wide applicability. Incorporating MB0601 into noodles, dairy products, pizza, bread, and other wheat-based foods makes it possible to produce gluten-degraded products. As a result, MB1 provides a valuable solution for people with gluten intolerance, sensitivity, or allergies, making wheat-based foods easier to enjoy.
Strain
Lactobacillus plantarum MB0601
Type
Heat-treated strain
Specification
10^6 ~ 10^11 cell/g
Registered Applications
General food additives
Patent (1)
Title: Lactobacillus plantarum MB0601 strain with gluten-degrading properties and its applications
MB2
MB2 is a heat-treated probiotic derived from the patented gluten-degrading strain GLU70. Developed as a stable postbiotic powder, it retains the beneficial properties of GLU70 and has been patented for its ability to prevent, improve, or potentially treat inflammatory bowel conditions caused by gluten. Even though it is not a live strain, MB2 has been shown to maintain its beneficial effects, making it suitable for food applications that require heat stability such as baking and thermal processing.
The parent strain GLU70 (Lactobacillus paracasei GLU70) is patented for breaking down gluten while also preventing or improving inflammatory bowel diseases triggered by gluten. GLU70 was found to degrade gluten into digestible forms, reduce intestinal inflammation, and help restore intestinal mucosal cells.
Research on GLU70 in its heat-treated form (MB2) showed that higher intake of MB2 improved gliadin-induced intestinal damage, reduced inflammation, and increased pancreatic enzyme activity compared with the control group.
Strain
Lactobacillus paracasei GLU70
Type
Heat-treated strain
Specification
10^6 ~ 10^11 cell/g
Registered Applications
General food additives
Patent (1)
Title: Composition containing heat-treated Lactobacillus paracasei GLU70 with gluten-degrading properties for the prevention, improvement, or treatment of gliadin-induced inflammatory bowel disease
Dipro-rhamnosus
Dipro-rhamnosus is a postbiotic derived from the patented probiotic strain DS0508. Developed as a heat-stable functional ingredient, it is suitable for use in foods, additives, and other applications requiring thermal processing.
DS0508 was patented for its ability to induce the browning of fat cells, offering potential benefits for the prevention and management of obesity. Browning is the process where white fat cells, which store energy, are converted into brown fat cells, which burn energy, generate heat, and support balance in the body.
Research has shown that DS0508 activates energy use, prevents fat accumulation, reduces fat cell size, and lowers blood lipid levels such as total cholesterol and LDL. These findings highlight its potential as an effective solution for weight management and metabolic health.
Strain
Lactobacillus rhamnosus DS0508
Type
Heat-treated strain
Specification
10^6 ~ 10^11 cell/g
Registered Applications
General food additives
Patent (1)
Title: Novel Lactobacillus rhamnosus DS0508 strain with preventive or therapeutic effects against obesity and its applications
Publication (1)
1) Bifidobacterium longum DS0956 and Lactobacillus rhamnosus DS0508 culture-supernatant ameliorate obesity by inducing thermogenesis in obese-mice. Beneficial Microbes (2020).
INF1
INF1 is a patented heat-treated probiotic derived from the strain KR-050L. Recognized for its potential in the prevention and treatment of inflammatory diseases, it is developed as a stable postbiotic powder suitable for use in foods, cosmetics, and other products requiring heat processing.
KR-050L was licensed for exclusive applications in food, cosmetics, and pet products. Research has shown that the KR-050L postbiotic suppresses substances that trigger inflammation in the body. In studies, it alleviated symptoms of atopic dermatitis in animal models and demonstrated effectiveness in reducing intestinal inflammation as well as other conditions linked to inflammation.
Strain
Lactococcus lactis KR-050L
Type
Heat-treated strain
Specification
10^6 ~ 10^11 cell/g